Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:ferric_carboxymaltose
|
| gptkbp:approvalYear |
2007
|
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:ATCCode |
B03AC
|
| gptkbp:contraindication |
iron overload
anemia not caused by iron deficiency hypersensitivity to ferric carboxymaltose |
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ferinject
|
| gptkbp:indication |
chronic kidney disease
patients intolerant to oral iron patients with poor response to oral iron |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Vifor_Pharma
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Europe gptkb:Japan gptkb:United_States |
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
B3 (Australia) Not assigned (US) |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
dizziness hypertension hypophosphatemia |
| gptkbp:usedFor |
iron deficiency anemia
|
| gptkbp:bfsParent |
gptkb:Vifor_Pharma
|
| gptkbp:bfsLayer |
7
|